gxp audits, consulting & inspections

Servicing All GxPs Across All Regulatory Phases
GxP Audits Header GxP Audits Header
quality-compliance

1,000+ Audits Performed in the Last Two Years

patient-support-programs

200+ Clients Served in the US and Internationally

global-submissions

350+ Compliance Auditors Located in 30+ Countries

authority-meetings

33 Languages Supported

Colorized half circle.
Male GxP auditor standing with arms crossed wearing grey jacket

Global Auditing Program

Auditing is an integral part of the GxP landscape as companies must be compliant with regulatory requirements to move to the next phase of development and maintain their place in the market. ProPharma serves as an extension of your clinical and commercial quality departments, collaborating closely to evaluate internal and vendor systems for compliance and quality improvements. 

Enhance your quality and compliance journey with our global team of dynamic auditors. Whether you require single audits or comprehensive vendor management programs, we deliver bespoke audit support that meets your specific needs. Our expertise spans across all regulatory lifecycle stages, ensuring alignment with the latest industry trends, evolving regulations, and standards in GxP auditing.

GxP Consulting & Audit Services

With a wealth of experience, our auditors specialize in conducting a wide range of audits and assessments. From comprehensive compliance audits to assisting with health authority inspections and pre-approval preparations, we provide comprehensive support throughout the audit process.

With offices and compliance consultants located around the world, ProPharma offers the capability to execute audits in different GxP areas on a global scale, creating efficiency and savings. Our large team of qualified auditors has a breadth of expertise across the entire development and regulatory spectrum, including the European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), United States Food and Drug Association (FDA), Japan Pharmaceuticals and Medical Devices Agency (PDMA), Health Canada, ISO-13485, ISO-9001, CAP/CLIA, Computer Systems Validation (CSV), Digital Compliance Audits, and Data Integrity.

ProPharma's team of experts excels in identifying potential areas of improvement, enhancing compliance, and optimizing your operations in alignment with regulations and industry best practices. Our comprehensive approach and expert knowledge ensure that your organization maintains the highest standards of quality and regulatory compliance across the GxP landscape.

Vendor Audits

Good Manufacturing Practice (GMP) Audits

We offer comprehensive cGMP (Current Good Manufacturing Practice) compliance audits tailored to your specific needs, whether it's for an initial qualification of your vendor or recurring audits. Our highly experienced team conducts audits with a focus on independence and impartiality, providing you with valuable insights and actionable recommendations for improvement. We specialize in conducting audits across various GMP industries, including:

  • Drug product/drug substance
  • Devices and components
  • Excipients and raw materials
  • GDP – warehouse and distribution
  • GMP laboratories
professional-looking-at-two-monitors-with-data-and-graphs

Good Clinical Practice (GCP) Audits

ProPharma's GCP (Good Clinical Practice) Auditors specialize in conducting thorough and comprehensive GCP Audits, offering assurance that your clinical studies, whether ongoing or planned, are conducted in compliance with regulatory requirements. Our audits provide valuable insights and recommendations to ensure clinical study compliance success. We focus on various key areas, including:

  • Clinical Research Organization (CRO)
  • Investigator Sites
  • Trial Master Files (TMF)
  • Good Clinical Laboratory Practice (GCLP)

IT Vendor Audits

Regulators require assessment and approval for suppliers of critical software applications, IT infrastructure, and IT support services.  ProPharma has the expertise to assess system functionality and vendors’ quality management practices for compliance with regulations such as Part 11 and Annex 11. Additionally, we assess your IT vendor’s SDLC and testing methodologies so you will have the documentation to support your computer system validation strategy.  Our audit services include:

  • Software, SaaS, and PaaS vendor audits
  • IT infrastructure and IaaS vendor audits 
  • IT service and validation provider vendor audits

Good Laboratory Practice (GLP) Audits

ProPharma specializes in conducting comprehensive GLP (Good Laboratory Practice) Audits, ensuring that pre-clinical and clinical laboratory activities are appropriately managed and comply with regulatory requirements. Our audits cover a wide range of areas, including animal studies, toxicological assessments, pharmacokinetics (PK) studies, and clinical laboratory specimen testing. Our experienced auditors identify potential areas for improvement, ensure the welfare of laboratory animals, and verify the accuracy and reliability of laboratory data. We focus on various key components of GLP auditing, including:

  • Nonclinical labs
  • Animal use and care

Postmarket Surveillance Audits

ProPharma's Postmarket Surveillance Audits evaluate the intake of drug and device safety data, compliance with reporting requirements, and adherence to timelines. Our audits focus on key areas within post-market surveillance, and our team provides detailed assessments to ensure regulatory compliance and enhance patient safety. Our expertise covers the following aspects:

  • Pharmacovigilance (PV)
  • Complaint management
  • Digital Information and Internet Systems (IT/IS)


Request a GxP Audit

Inspection Readiness

professionals-looking-at-whiteboard

Our inspection readiness auditing encompasses pre-approval inspection (PAI) readiness or mock inspection and gap analysis prior to the inspection by a regulatory agency. Our team of inspection readiness auditors has experience with over 60 regulatory inspections undertaken by various agencies including the MHRA (UK), HPRA (Ireland), EMA, SUKL (Czech Republic), FDA (US), Korean FDA, Turkish MOH, MCC South Africa, Anvisa Brazil, at sites in Argentina, Bangladesh, Czech Republic, England, India, Nordics, Belgium, Germany, The Netherlands, Switzerland, and Ireland. 

Our Inspection Readiness Services Include:

  1. Pre-Approval Regulatory Inspections in all GxP areas: Ensuring your organization is fully prepared for regulatory assessments
  2. Mock Regulatory Inspections in all GxP Areas: Practicing simulated inspections to identify and address potential issues proactively.
  3. Guidance on Corrective Actions: Providing insight into necessary corrective actions and validations before the regulatory inspection, avoiding potential non-compliance citations.
  4. Training for Successful Regulatory Inspection: Preparing your team for interviews, interactions, and best practices during regulatory agency visits.
  5. Inspection Readiness Reviews: Crucial, especially with the increasing frequency of unannounced inspections.
  6. Compliance-Level Review for License Applications: Assessing compliance with best practice standards for obtaining or retaining essential licenses like Manufacturer's/Importation Authorisation (MIA), Wholesale Distributor Authorisation (WDA), Marketing Authorization (MA), GMP, and GDP.

Ensure your organization is inspection-ready with our comprehensive audit services, tailored to meet your GxP compliance needs and ensure seamless interactions with regulatory agencies.

Speak to an Inspection Expert

Quality Management System Gap Assessments

Providing a risk-based "right-sized" approach, our compliance experts evaluate the current state of an organization’s Quality Management System for compliance with regulatory requirements and best industry practices. Our compliance experts will seamlessly integrate with your team to do more than simply identify potential risks. We provide recommendations to mitigate those risks and can work side-by-side with you to implement improvement plans and support your staff in addressing those risks. 

Request an Audit

Data Integrity Gap Assessments

ProPharma assesses real-world situations vs. the principles of ALCOA to identify data integrity risks. We have drawn from international regulations, regulatory guidance documents, FDA Warning Letters, and decades of professional experience to develop comprehensive tools for assessing policies, procedures, and systems to detect data integrity risks.  Our standardized approach to performing data integrity gap assessments encompasses the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Our mission is to provide the information you need to mitigate data integrity risks before your organization has a data integrity issue. 

Other Audit Services

Professionals around conference table smiling pointing at papers with data graphs

Return To Service Audits

When our clients seek assistance in remedying regulatory agency actions, such as a warning letter, ProPharma recommends a multi-stage approach. Warning letters are typically issued by agencies when they perceive a lack of control in healthcare products manufacturing. As part of the remediation process, the company is expected to evaluate the state of compliance across the entire organization and remediate all observed compliance issues. ProPharma’s approach involves conducting comprehensive GMP Baseline Assessments across 31 Quality System Elements (QSE) that roll up to the six-systems inspection methodology. 

Due Diligence

ProPharma's Quality & Compliance team possesses extensive expertise in conducting Due Diligence audits for firms undergoing mergers or acquisitions. These audits involve comprehensive assessments of the target companies' quality systems to evaluate their current state and provide a thorough measure of the risk associated with potential compliance faults.

Our auditors carefully examine various aspects of the target company's operations, including quality management systems, standard operating procedures, documentation practices, training programs, and regulatory compliance records. By conducting these assessments, we enable clients to gain a comprehensive understanding of the target company's compliance status, potential risks, and areas that require remediation.

We focus on identifying any compliance gaps or deficiencies that may impact the integration process. Working collaboratively with our clients, we develop effective mitigation strategies. Leveraging our expertise and attention to detail, we assist our clients in mitigating compliance risks, optimizing their due diligence process, and ensuring a seamless transition during mergers or acquisitions.

Internal Audits

Our experienced auditors can also help companies evaluate and improve their internal controls and compliance. We review policies, procedures, and documentation, analyze risk management practices, and conduct interviews with key personnel. We collaborate closely with clients, offering actionable recommendations and assisting with corrective action plans. With ProPharma's expertise, organizations can strengthen their internal processes and achieve operational excellence.

Request an Audit

Our GxP Audit & Consulting Approach

ProPharma's Quality & Compliance consultants provide a foundation of quality expertise across the landscape of regulatory expectations. We bring established quality processes to quickly navigate compliance solutions and assessment of risk to help identify, build, and maintain compliance to the ever-changing regulatory expectations. Our dedicated team of subject matter experts works to ensure that each individual project is successful.

Audit Preparation

Audit Execution

Post Audit Deliverables

Audit Coordination Team

Each client is aligned with a dedicated Audit Coordinator, serving as the point of contact who will facilitate the management of audit logistics, periodic progress meetings, timelines, and completion of deliverables between client/sponsor, auditor, and auditee.

We'll also assign a subject matter expert (SME) compliance consultant who will serve as technical support for audit process and peer review of deliverables and outputs.

GxP Auditor

Assigned on a per audit basis, we’ll match you with an auditor who has the background, experience, and expertise aligned with the audit scope, geographic location, and project timing.

The assigned auditor(s) will be trained on any relevant Standard Operating Procedures (SOPs) of the client when requested.

Audit Preparation

Audit scope and timelines will be agreed upon with the client. As required, Sponsor procedures and templates may be used for audit preparation, conduct, and follow-up.

A briefing meeting to ensure full alignment with client in case of specific requirements may be part of the preparations.

An Agenda / Plan will be developed to formally agree upon the audit details (purpose, scope, criteria, activities, etc.) with client.

Virtual / On-site Audits

ProPharma has extensive experience performing both in-person and virtual audits. In the event of virtual audits, our audit coordination team provides an additional level of technical support to ensure that document sharing, application access, and web conferencing are aligned prior to audit onset to avoid delays.

Audit Scheduling

ProPharma utilizes a validated audit scheduling database to ensure that all audits and deliverables are managed to client timelines and expectations.

The audit dates and plan will be confirmed with the vendor (e.g., Clinical Research Organizations (CRO), laboratory, manufacturer, etc.).

For preparation purposes, some documents may be requested from the site and/or Client prior to the assessment.

Audit Execution

During the Audit Execution phase, we execute the audit according to the agenda/plan. This includes reviewing roles and responsibilities, conducting facility tours, interviews, material reviews, and daily debrief meetings.

We analyze observations, make recommendations, and identify areas of positive performance.

Our auditors follow a specific audit execution methodology for the appropriate GxP type and lifecycle stage.

Peer Review

ProPharma's team of compliance consultants will perform a technical and quality peer review of all deliverables prior to submittal to the client to ensure consistency and compliance accuracy.

Deliver Final Report

A final report will be drafted based on a pre-determined format agreed upon with the client.

Debrief Meeting

A debriefing meeting with the Client following the assessment may be part of the arrangements.

Deficiency Classification

Deficiencies are typically categorized as critical, major, or minor. Comments or recommendations may be included in the report, including recommendations to ensure compliance or inspection readiness of the auditee. The responsibility for addressing the finding (sponsor/CRO, investigator, vendor, etc.) may also be included.

Post Audit Support & CAPA Management

ProPharma offers Post Audit Support and CAPA Management services to assist clients in resolving CAPA items identified during audits. Our expert consultants provide administrative support by tracking and compiling CAPA commitments, conducting auditor adequacy reviews, and offering CAPA remediation assistance. We ensure regulatory compliance, address root causes, and drive continuous improvement.

Audit Preparation

Click here to expand this section

Audit Coordination Team

Each client is aligned with a dedicated Audit Coordinator, serving as the point of contact who will facilitate the management of audit logistics, periodic progress meetings, timelines, and completion of deliverables between client/sponsor, auditor, and auditee.

We'll also assign a subject matter expert (SME) compliance consultant who will serve as technical support for audit process and peer review of deliverables and outputs.

GxP Auditor

Assigned on a per audit basis, we’ll match you with an auditor who has the background, experience, and expertise aligned with the audit scope, geographic location, and project timing.

The assigned auditor(s) will be trained on any relevant Standard Operating Procedures (SOPs) of the client when requested.

Audit Preparation

Audit scope and timelines will be agreed upon with the client. As required, Sponsor procedures and templates may be used for audit preparation, conduct, and follow-up.

A briefing meeting to ensure full alignment with client in case of specific requirements may be part of the preparations.

An Agenda / Plan will be developed to formally agree upon the audit details (purpose, scope, criteria, activities, etc.) with client.

Audit Execution

Click here to expand this section

Virtual / On-site Audits

ProPharma has extensive experience performing both in-person and virtual audits. In the event of virtual audits, our audit coordination team provides an additional level of technical support to ensure that document sharing, application access, and web conferencing are aligned prior to audit onset to avoid delays.

Audit Scheduling

ProPharma utilizes a validated audit scheduling database to ensure that all audits and deliverables are managed to client timelines and expectations.

The audit dates and plan will be confirmed with the vendor (e.g., Clinical Research Organizations (CRO), laboratory, manufacturer, etc.).

For preparation purposes, some documents may be requested from the site and/or Client prior to the assessment.

Audit Execution

During the Audit Execution phase, we execute the audit according to the agenda/plan. This includes reviewing roles and responsibilities, conducting facility tours, interviews, material reviews, and daily debrief meetings.

We analyze observations, make recommendations, and identify areas of positive performance.

Our auditors follow a specific audit execution methodology for the appropriate GxP type and lifecycle stage.

Post Audit Deliverables

Click here to expand this section

Peer Review

ProPharma's team of compliance consultants will perform a technical and quality peer review of all deliverables prior to submittal to the client to ensure consistency and compliance accuracy.

Deliver Final Report

A final report will be drafted based on a pre-determined format agreed upon with the client.

Debrief Meeting

A debriefing meeting with the Client following the assessment may be part of the arrangements.

Deficiency Classification

Deficiencies are typically categorized as critical, major, or minor. Comments or recommendations may be included in the report, including recommendations to ensure compliance or inspection readiness of the auditee. The responsibility for addressing the finding (sponsor/CRO, investigator, vendor, etc.) may also be included.

Post Audit Support & CAPA Management

ProPharma offers Post Audit Support and CAPA Management services to assist clients in resolving CAPA items identified during audits. Our expert consultants provide administrative support by tracking and compiling CAPA commitments, conducting auditor adequacy reviews, and offering CAPA remediation assistance. We ensure regulatory compliance, address root causes, and drive continuous improvement.

Meet Our GxP Experts & Consultants

James Meckstroth

James Meckstroth

Director, Compliance & Quality Assurance

Laurie Rouse

Laurie Rouse

Global Audit Coordination Manager

Catrin Jones

Catrin Jones

Consultant, Compliance and Quality Assurance

Matt Hermon

Matt Hermon

Principal Compliance Consultant

Gradient Image

Customized Strategy. Globally Scaled Solutions.

ProPharma's ability to execute audits in different GxP areas on a global basis with diverse language skills creates efficiencies in both time and money. Our experienced team of qualified auditors from around the world is here to support the entire development and regulatory spectrum.

Compliance Auditing: Diving into Common Critical Findings

Discover the crucial role of compliance auditing in the healthcare industry with our in-depth whitepaper, now available for download. Our report takes an insightful look at the common critical audit findings noted by Health Authorities and our expert GxP Compliance Auditors, reinforcing the indispensable need for healthcare companies to follow stringent standards laid down by prominent global regulatory bodies.

Download: Compliance Auditing: Diving into Common Critical Findings

compliance-auditing-whitepaper

 

News & Insights

General Regulatory FDA Meetings Regulatory Sciences Formal FDA Meetings for Sponsors or Applications of PDUFA Products

February 26, 2024

Formal FDA Meetings for Sponsors or Applications of PDUFA Products

This article has been updated since its original February 28, 2017 publication. Since the introduction of the Prescription Drug User Fee Act (PDUFA) VII for fiscal years 2023 - 2027, the FDA...

FDA Regulatory Sciences The Impact of a US Government Shutdown on the Food and Drug Administration

February 26, 2024

The Impact of a US Government Shutdown on the Food and Drug Administration

This article was originally published in September 2023, and has been updated to reflect an upcoming potential government shutdown. As U.S. lawmakers return from the President’s Day holiday, they are...

Meet the Expert Medical Information Meet the Expert: Eric Brandon

February 22, 2024

Meet the Expert: Eric Brandon

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Press Releases ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

January 24, 2024

ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

RALEIGH, January 24, 2024, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey...

Company News Press Releases Innovation and the Black Swan Prodigy Whitepaper

January 4, 2024

Innovation and the Black Swan Prodigy Whitepaper

Check out our comprehensive whitepaper, "Innovation and the Black Swan: the Imperative of AI-enabled clinical research," for an in-depth look at how embracing AI-enabled tools and technologies is...

Press Releases ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

January 4, 2024

ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

Whitepaper published alongside today's announcement details $5M+ investment and up to 50% improvement in speed, quality, and cost with new AI-enhanced solutions. RALEIGH, NC, January 4, 2023 –...

Press Releases Awards EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...

Press Releases Awards ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

Press Releases Awards ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

August 15, 2023

ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

Press Releases ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

January 24, 2024

ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

RALEIGH, January 24, 2024, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey...

Company News Press Releases Innovation and the Black Swan Prodigy Whitepaper

January 4, 2024

Innovation and the Black Swan Prodigy Whitepaper

Check out our comprehensive whitepaper, "Innovation and the Black Swan: the Imperative of AI-enabled clinical research," for an in-depth look at how embracing AI-enabled tools and technologies is...

Press Releases ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

January 4, 2024

ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

Whitepaper published alongside today's announcement details $5M+ investment and up to 50% improvement in speed, quality, and cost with new AI-enhanced solutions. RALEIGH, NC, January 4, 2023 –...

Previous Post Arrow Next Post Arrow
%}
Press Releases Awards EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...

Press Releases Awards ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

Press Releases Awards ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

August 15, 2023

ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...

Previous Award Arrow Next Award Arrow
General Regulatory FDA Meetings Regulatory Sciences Formal FDA Meetings for Sponsors or Applications of PDUFA Products

February 26, 2024

Formal FDA Meetings for Sponsors or Applications of PDUFA Products

This article has been updated since its original February 28, 2017 publication. Since the introduction of the Prescription Drug User Fee Act (PDUFA) VII for fiscal years 2023 - 2027, the FDA...

FDA Regulatory Sciences The Impact of a US Government Shutdown on the Food and Drug Administration

February 26, 2024

The Impact of a US Government Shutdown on the Food and Drug Administration

This article was originally published in September 2023, and has been updated to reflect an upcoming potential government shutdown. As U.S. lawmakers return from the President’s Day holiday, they are...

Meet the Expert Medical Information Meet the Expert: Eric Brandon

February 22, 2024

Meet the Expert: Eric Brandon

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and...

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow